Furthermore, CSCs have been documented to evade immunotherapy’s therapeutic effects with high PD-L1 expression and promote a highly immune-suppressive microenvironment in a manner more robust than typical tumor cells [133,137]. This evidence concerns the gene CD274 and neoplasm.